Executive in Residence
Amanda joined Frazier Healthcare Partners in September 2021, as an Executive in Residence on the Growth Buyout team. She will work alongside the firm to develop and execute investment strategies focused on differentiated outsourced pharmaceutical contract manufacturing and scientific services enabling advanced therapies.
Amanda brings over 20 years of experience in the pharmaceutical products and services industry. Prior to joining Frazier, Amanda served as the President of Drug Product Services for Thermo Fisher Scientific, where she held responsibility for drug product development and commercial manufacturing of oral solid and sterile injectable drug products. Prior to her tenure at Thermo Fisher Scientific, Amanda held several leadership roles of increasing responsibility across pharmaceutical development, operations, strategy and innovation, as well as commercial functions for Patheon Pharmaceuticals, a pharma services solution provider for drug development, clinical trial logistics, and commercial manufacturing.
Amanda holds a Bachelor of Science in Chemical Engineering from the University of Cincinnati and Advanced Management Executive Program from Harvard Business School. Amanda is actively involved in the community and various philanthropic institutions with a focus on helping children and families in need. Additionally, she serves as an active mentor in the development and expansion of female leadership.